Undervalued Drug Manufacturer Stocks on TSX May 2025

May 04, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
PCLO PharmaCielo 0.07 0.17 163.40 155246 11 0.00 0.0
DB Decibel Cannabis Co 0.07 0.13 92.12 120782 30 0.00 2.3
AQS Aequus Pharmaceuticals 0.01 0.01 70.46 146500 1 0.00 0.0
CANB CanadaBis Cap 0.05 0.08 65.19 255113 7 0.00 0.0
LFST Lifeist Wellness 0.04 0.06 63.29 23193 1 0.00 0.0
NAV Navco Pharmaceuticals 0.01 0.01 33.00 4095 0 0.00 0.0
GENX Genix Pharmaceuticals 0.03 0.04 29.34 7190 2 0.00 0.0
ROMJ Rubicon Organics 0.47 0.57 21.95 31210 28 0.00 0.0
LSL LSL Pharma Group 0.39 0.44 12.99 46766 45 0.00 0.0
RX Biosyent 10.95 11.75 7.31 5052 129 1.69 17.8
All data provided as at market close May 01, 2025.

Company Details

PharmaCielo

PCLO:TSX-V

Close Price

0.07

Our Valuation

0.17

% Difference

163.40

Market Cap ($M)

11

P/E Ratio

0.0

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

Access the stockcalc valuation


Decibel Cannabis Co

DB:TSX-V

Close Price

0.07

Our Valuation

0.13

% Difference

92.12

Market Cap ($M)

30

P/E Ratio

2.3

Decibel Cannabis Co Inc is engaged in the cannabis operations business. It is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers as well as the direct sale of products through its retail locations to end customers.

Access the stockcalc valuation


Aequus Pharmaceuticals

AQS:TSX-V

Close Price

0.01

Our Valuation

0.01

% Difference

70.46

Market Cap ($M)

1

P/E Ratio

0.0

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Access the stockcalc valuation


CanadaBis Cap

CANB:TSX-V

Close Price

0.05

Our Valuation

0.08

% Difference

65.19

Market Cap ($M)

7

P/E Ratio

0.0

CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Lifeist Wellness

LFST:TSX-V

Close Price

0.04

Our Valuation

0.06

% Difference

63.29

Market Cap ($M)

1

P/E Ratio

0.0

Lifeist Wellness Inc is a portfolio wellness company leveraging advancements in science and technology. Its portfolio of brands includes; CannMart Inc, a distributor of licensed and in-house branded adult-use cannabis and cannabis-derived products in Canada; CannMart Marketplace Inc operates CannMart.com, an online marketplace for hemp-derived CBD and accessories in the U.S.

Access the stockcalc valuation


NAV:TSX-V

Close Price

0.01

Our Valuation

0.01

% Difference

33.00

Market Cap ($M)

0

P/E Ratio

0.0

Navco Pharmaceuticals Inc is engaged in creating nanotechnology products using computer algorithms. The products are used in various industries like medicine, textiles, chemicals, and additives to combat microorganisms such as viruses and bacteria. Its products include aerosol sprays, hand cleansers, hand creams, and nano BioGuard(tm)-Silver.

Access the stockcalc valuation


Genix Pharmaceuticals

GENX:TSX-V

Close Price

0.03

Our Valuation

0.04

% Difference

29.34

Market Cap ($M)

2

P/E Ratio

0.0

Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops.

Access the stockcalc valuation


Rubicon Organics

ROMJ:TSX-V

Close Price

0.47

Our Valuation

0.57

% Difference

21.95

Market Cap ($M)

28

P/E Ratio

0.0

Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.

Access the stockcalc valuation


LSL Pharma Group

LSL:TSX-V

Close Price

0.39

Our Valuation

0.44

% Difference

12.99

Market Cap ($M)

45

P/E Ratio

0.0

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

Access the stockcalc valuation


Biosyent

RX:TSX-V

Close Price

10.95

Our Valuation

11.75

% Difference

7.31

Market Cap ($M)

129

P/E Ratio

17.8

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
PharmaCielo and Decibel Cannabis are the most undervalued Drug Manufacturers stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-may-2025
PharmaCielo $PCLO and Decibel Cannabis $DB are the most undervalued Drug Manufacturers stocks on the #TSX. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-may-2025
PharmaCielo and Decibel Cannabis are the most undervalued Drug Manufacturers stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-may-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.